Hepatitis C positive grafts may be used in orthotopic liver transplantation: A matched analysis

American Journal of Transplantation

Volumn 3, Issue 9, 2003, Pages 1167-1172

  Saab, Sammy ^a,b   Ghobrial, Rafik M ^b   Ibrahim, Ayman B ^b   Kunder, Gregg ^b   Durazo, Francisco ^a,b   Han, Steven ^a,b   Farmer, Douglas G ^b   Yersiz, Hasan ^b   Goldstein, Leonard I ^b   Busuttil, Ronald W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clinical outcomes; Hepatitis C; Liver transplantation

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; ISCHEMIA; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; RECURRENT DISEASE; SURVIVAL;

ADULT; BODY WEIGHT; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPATITIS C; HUMANS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MIDDLE AGED; PATIENT SELECTION; RETROSPECTIVE STUDIES; SODIUM; SURVIVAL ANALYSIS; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 12444255254     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00189.x     Document Type: Article

References (27)

1. Ghobrial RM, Steadman R, Gornbein J et al. A 10-year experience of liver transplantation for hepatitis C analysis of factors determining outcome in over 500 patients. Ann Surg 2001; 234: 384-393.
2. United Network for Organ Sharing Web Site: Available at www.unet.org. 2001.
3. Llach J, Gines P, Arroyo V et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988; 94: 482-487.
4. Saunders JB, Walters JR, Davies AP et al. A 20-year prospective study of cirrhosis. Br Med J (Clin Res Ed) 1981; 282: 263-266.
5. Gines P, Sanchez-Fueyo A, Fernandez-Esparrach G. Prognostic value of water excretion in cirrhosis with ascites. J Am Soc Nephrol 1996; 7: 1387.
6. Sheiner PA, Mor E, Schwartz ME et al. Use of hepatitis C-positive donors in liver transplantation. Transplant Pro 1993; 25: 3071.
7. Vargas HE, Laskus T, Wang LF et al. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology 1999; 117: 149-153.
8. Torres M, Weppler D, Reddy KR et al. Use of hepatitis C-infected donors for hepatitis C-positive OLT recipients. Gastroenterology 1999; 117: 1253.
9. Testa G, Goldstein RM, Netto G et al. Long-term outcome of patients transplanted with livers from hepatitis C-positive donors. Transplantation 1998; 65: 925-929.
10. Marroquin CE, Marino G, Kuo PC et al. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers. Liver Transplant 2001; 7: 762-768.
11. Velidedeoglu E, Desai NM, Campos L et al. The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation 2002; 73: 582-587.
12. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end stage liver disease. Hepatology 2001; 33: 464-470.
13. Wiesner R, Edwards E, Freeman R et al. The United Network for Organ Sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96.
14. Desmet VJ, Gerber M, Hoofnagle JH et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520.
15. Charlton M, Seaberg E, Wiesner R et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28: 823-830.
16. Armitage P, Berry G. Statistical Methods in Medical Research, 3rd edn. Oxford: Blackwell Scientific Publications; 1994.
17. Afifi AA, Clark V. Computer-Aided Multivariate Analysis, 3rd edn. Baca Raton, FL: Chapman & Hall; 1994.
18. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus infection and HCV-related chronic disease. MMWR 1998; 47: 1-39.
19. Wong LL, McFall P, Wong LMF. The cost of dying of end-stage liver disease. Arch Intern Med 1997; 157: 1429-1432.
20. Berenguer M, Prieto M, Rayon JM et al. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology 2000; 32: 852-858.
21. Feray C, Caccamo L, Alexander GJ et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology 1999; 117: 619-625.
22. Pawlotsky JM. Measuring hepatitis C viremia in clinical samples: can we trust the assays? Hepatology 1997; 26: 1-4.
23. Wright TL, Donegan E, Hsu HH et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103: 317-322.
24. Gane EJ, Naoumov NV, Qian KP et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996; 110: 167-177.
25. Bizollon T, Ducerf C, Trepo C et al. Hepatitis C virus recurrence after liver transplantation. Gut 1999; 44: 575-578.
26. Shuhart MC, Bronner MP, Gretch DR et al. Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology 1997; 26: 1646-1652.
27. Guido M, Fagiuoli S, Tessari G et al. Histology predicts cirrhotic evolution of post transplant hepatitis C. Gut 2002; 50: 697-700.